Last update:
Oncology news
Successfully treated acute myeloid leukemia patients may hold the key to new CAR T cell therapy
Developing effective immunotherapies for acute myeloid leukemia (AML) has long been hampered by a critical challenge: Therapy directed at killing the leukemia cells may also harm the body's ability to make new, healthy blood ...
7 hours ago
0
6
AI-powered handheld microscope aims to spot cancer earlier
Researchers at Rice University and The University of Texas MD Anderson Cancer Center have developed a compact, artificial intelligence-powered imaging device that could transform how clinicians detect cancer. The technology, ...
9 hours ago
0
5
Ivermectin prescriptions more than double after celebrity endorses it as a cancer treatment on a high-profile podcast
Prescriptions for the anti-parasite medication ivermectin doubled in the months following an endorsement by a celebrity during a high-profile podcast as an off-label cancer treatment, a UCLA-led study finds.
15 hours ago
0
15
Hidden cell 'message route' could shift cancer research
A team at Huntsman Cancer Institute at the University of Utah (the U) has uncovered a previously unrecognized molecular mechanism by which cells send signals to one another—an insight that could help researchers better understand ...
13 hours ago
0
4
Role of RNA binding protein with multiple splicing in acute myeloid leukemia revealed
Acute myeloid leukemia (AML) is one of the most aggressive blood cancers and is characterized by the rapid growth of immature myeloid precursor cells. It predominantly affects elderly people, and current treatment options ...
10 hours ago
0
5
First-in-human trial demonstrates promise of implantable cytokine factories for ovarian cancer
Implantable cytokine factories designed to deliver immunotherapy directly at the site of disease have taken an important step toward clinical reality. Researchers at Rice University, in collaboration with The University of ...
9 hours ago
0
2
Personalized vaccine shows promise against aggressive brain cancer
A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people in the U.S., is safe and elicits robust and broad immune responses that appear to increase recurrence-free ...
21 hours ago
0
9
Novel molecular marker may improve prostate cancer treatment
Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on lowering androgen levels or blocking their activity, but many tumors eventually become resistant and ...
11 hours ago
0
3
Gene-edited stem cell transplant shows promise for aggressive blood cancers
For highly aggressive types of blood cancer, stem cell transplantation is often the only potentially curative therapy, yet even after a transplant, these cancers often return. Now a clinical trial, led by researchers at Washington ...
21 hours ago
0
6
Novel vision-language model to support diagnosis using CT scans
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, making early and accurate diagnosis essential for improving patient outcomes. Chest computed tomography (CT) scans are widely used to detect ...
8 hours ago
0
1
Reducing animal suffering in cancer research with fetal bovine serum-free cell culture models
For decades, human cancer cell lines have been indispensable models for cancer research, already replacing a significant number of animal experiments. However, the use of fetal bovine serum (FBS) in their cultivation is easily ...
9 hours ago
0
1
Vitamin B12: The essential nutrient with a complicated cancer link
We've all heard the advice: eat your fruit and vegetables, get your vitamins, and stay healthy. For the most part, that guidance holds up. But some nutrients have a more complicated story, and vitamin B12 is a fascinating ...
12 hours ago
0
4
FDA clears ArteraAI Breast for breast cancer risk stratification
The U.S. Food and Drug Administration has cleared ArteraAI Breast for use in patients with early-stage, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative invasive breast cancer.
11 hours ago
0
2
Study suggests immunotherapy may strengthen treatment for aggressive prostate cancer
Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy can improve results when added to a radiotherapy-based treatment regimen for men with aggressive prostate ...
16 hours ago
0
3
A common cholesterol drug may weaken ovarian cancer's hidden shield
Ascites—the buildup of liquid in the belly—may be doing more than causing discomfort. A Duke University School of Medicine study finds this fluid helps cancer cells survive and spread—and that a decades-old cholesterol drug ...
May 11, 2026
0
9
Slow-dividing breast cancer cells may explain relapses decades after treatment
A new study by the Garvan Institute of Medical Research has uncovered a hidden mechanism explaining why breast cancer can return many years after successful treatment. Published in Nature Communications, the research reveals ...
May 11, 2026
0
10
Testosterone treatment found to improve sexual and physical function for men after prostate cancer surgery
Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But radical prostatectomy—surgery to remove the prostate—can lead to sexual and physical dysfunction, fatigue, ...
May 11, 2026
0
4
Single screening sigmoidoscopy linked to lower colorectal cancer risk two decades later
A randomized controlled trial of adults in Norway found that a single screening sigmoidoscopy led to a sustained reduction in colorectal cancer (CRC) incidence for more than two decades after screening, with women seeing ...
May 11, 2026
0
3
Cycling may boost stem cell donation with targeted cell release, pilot study suggests
A blood stem cell donation can save the lives of people with leukemia. To collect these cells from the bloodstream, donors are given medication that mobilizes blood stem cells from the bone marrow. A pilot study now suggests ...
May 11, 2026
0
1
FDA green lights Bizengri drug to treat rare, aggressive bile duct cancer
The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts.
May 11, 2026
0
1
Depression may be overdiagnosed in patients with ovarian cancer
People with ovarian cancer could be being overdiagnosed with depression due to the physical symptoms they experience as part of the cancer, according to international researchers. In addition to causing mental symptoms such ...
May 11, 2026
0
3
Public education key in new cervical cancer screening
As Canada moves to modernize cervical cancer screening, a new study suggests most women do not yet understand or trust the shift from the Pap test to human papillomavirus (HPV) based screening. The national survey, published ...
May 9, 2026
0
2
Urine test outperforms MRI for monitoring low-risk prostate cancer in new study
A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active surveillance. Use of the test to determine the need for repeat "monitoring" biopsies would have avoided up ...
May 8, 2026
0
15
Technology receives FDA approval for breast cancer treatment
More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering research into PROTACs (or PROteolysis TArgeting Chimera), a technology that treats certain types of cancer ...
May 8, 2026
0
9
IL-10 gene therapy boosts immune attack against liver cancer in mice
Researchers at National Taiwan University have developed a liver-directed IL-10 gene therapy that strengthens cancer-fighting immune cells and suppresses liver tumors in mice. The treatment also generated long-lasting immune ...
May 8, 2026
0
7
